Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-015330
Filing Date
2019-05-02
Accepted
2019-05-02 16:07:13
Documents
70
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aldr-10q_20190331.htm 10-Q 2149861
2 EX-10.4 aldr-ex104_238.htm EX-10.4 229771
3 EX-10.5 aldr-ex105_239.htm EX-10.5 11548
4 EX-31.1 aldr-ex311_8.htm EX-31.1 15507
5 EX-31.2 aldr-ex312_9.htm EX-31.2 15492
6 EX-32.1 aldr-ex321_6.htm EX-32.1 8566
  Complete submission text file 0001564590-19-015330.txt   7139379

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aldr-20190331.xml EX-101.INS 1319438
8 XBRL TAXONOMY EXTENSION SCHEMA aldr-20190331.xsd EX-101.SCH 56421
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldr-20190331_cal.xml EX-101.CAL 64800
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldr-20190331_def.xml EX-101.DEF 170967
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20190331_lab.xml EX-101.LAB 403110
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20190331_pre.xml EX-101.PRE 308617
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36431 | Film No.: 19791918
SIC: 2834 Pharmaceutical Preparations